IP Library Granted Patent US 8,563,726
Granted Patent B2
US 8,563,726 · App. 13/447,131 · Granted Oct 22, 2013

Stereoselective reduction of a morphinone

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,563,726
App. No.
13/447,131
Granted
Oct 22, 2013
Kind
B2
Abstract

A synthetic method is provided, wherein the method comprises stereoselectively reducing a ketone of a morphinone to form a reduced morphinone and optionally covalently attaching a water soluble polymer to the reduced morphinone.

Claims (12)

1. A synthetic method comprising:

stereoselectively reducing a ketone of a morphinone to a hydroxyl using a reducing agent selected from the group consisting of potassium tri-sec-butylborohydride and sodium tri-sec-butylborohydride to form a reduced morphinone, wherein the morphinone and the reduced morphinone have the following structures:

 respectively,

wherein R 1 is H or a hydroxyl protecting group; and

wherein the synthetic method has a conversion yield of 85% or greater of the ketone to the hydroxyl, and 99% or greater of the reduced morphinone is in an α epimer form.

2. The method of claim 1 , wherein R 1 is H.

3. The method of claim 1 , wherein R 1 is a hydroxyl protecting group selected from the group consisting of alkanoyl having 2 to 5 carbons; aryloyl having 7 to 11 carbons, benzyl, 1 ethoxyethyl, methoxymethyl, 4-methoxyphenylmethyl, methoxyethoxymethyl, 1 ethoxyethyl, benzyloxymethyl, (β trimethylsilylethoxy)methyl, tetrahydropyranyl, 2,2,2 trichloroethoxycarbonyl, t butyl(diphenyl)silyl, trialkylsilyl, trichloromethoxycarbonyl and 2,2,2-trichloroethoxymethyl.

4. The method of claim 3 , wherein R 1 is methoxyethoxymethyl.

5. The method of claim 1 , wherein the conversion yield is at least 95%.

6. The method of claim 5 , wherein the conversion yield is at least 98%.

7. The method of claim 1 , wherein the stereoselective reduction is performed in a solvent of tetrahydrofuran.

8. The method of claim 1 , wherein the reducing agent is potassium tri-sec-butylborohydride.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL 28571, FRAME 0141 Recorded Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036866/0700 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Oct 6, 2015
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 036796/0562 →
PARTIAL RELEASE OF PATENTS Recorded Mar 11, 2013
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 029964/0920 →
GRANT OF SECURITY INTEREST Recorded Jul 17, 2012
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 028571/0141 →